Showing results (791-800 of 19,545) with videos related to

Sort By:
Pageof 1,955
BMC Cancer|April 18, 2025
Early detection of triple-negative breast cancer: evidence of a favourable prognostic impact in a comparative analysis of screen-detected versus symptomatic casesIsabella Castellano, Stefano Rousset, Denise Casella, et al.
BMC Cancer|April 17, 2025
The influence of image selection and segmentation on the extraction of lung cancer imaging radiomics features using 3D-Slicer softwareChunmei Liu, Yuzheng He, Jianmin Luo
BMC Cancer|April 17, 2025
Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective studyJun-Shuai Xue, Nuersimanguli Maimaitiming, Bo-Lun Zhang, et al.
BMC Cancer|April 17, 2025
Real-world application of targeted next-generation sequencing for identifying molecular variants in Asian non-small-cell lung cancerFang-Yu Wang, Yi-Chen Yeh, Shin-Ying Lin, et al.
BMC Cancer|April 17, 2025
CD5 and p53 immunohistochemistry: valuable prediction method in molecular typing of CD5-positive diffuse large B-cell lymphomaHan Wang, Huaxiong Pan, Liling Zhang, et al.
BMC Cancer|April 23, 2025
Prognostic significance of preoperative Naples prognostic score for disease-free and overall survival in oral cavity squamous cell carcinoma post-surgeryXue-Lian Xu, Chen-Chen Wu, Hao Cheng
BMC Cancer|April 23, 2025
Adeno-associated virus-clustered regularly interspaced short palindromic repeats/cas9‑mediated ovarian cancer treatment targeting PD-L1Tamaki Yahata, Saori Toujima, Izumi Sasaki, et al.
BMC Cancer|April 15, 2025
Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapyShan Liao, Huiying Sun, Hao Lu, et al.
BMC Cancer|April 15, 2025
Dual Cas12a and multiplex crRNA CRISPR strategy ultrasensitive detection novel circRNA biomarker for the diagnosis of ovarian cancerLingxi Tian, Yan Gao, Lihan Zi, et al.
BMC Cancer|April 16, 2025
Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world studyJiajin Yang, Qiuping Xu, Sihao Luo, et al.
Pageof 1,955